Blood markers in women having IVF
Part of Blood & lymphatic, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at certain blood markers (related to metabolism and blood cells) in women who are going through IVF. Researchers want to understand how these markers might be linked to fertility, which could help improve treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 30 or older
- You are having trouble getting pregnant (infertility)
- Your body mass index (BMI) is between 18.5 and 38
- You do not have diabetes, thyroid problems, or other chronic conditions like liver, kidney, heart, or blood disorders
- You are not taking any medications that affect your blood sugar, thyroid, or cholesterol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “biomarkers” (test signals in your blood or cycle data) to better judge how ready the womb lining is during IVF. It compares two types of IVF hormone setups to see which approach best matches endometrial receptivity and supports successful embryo transfer.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
This trial looks for a blood test that could help predict infertility in women. If you are between 18 and 43, struggling with infertility or recurrent pregnancy loss, this study may be a fit.
This study uses a continuous glucose monitor to track blood sugar patterns in women undergoing their first or second IVF cycle. It aims to understand how glucose levels may relate to fertility treatments and outcomes.
This study measures changes in your blood immune markers during frozen embryo transfer when the embryo is chromosomally normal. It may help clinics understand what blood immune patterns relate to successful pregnancy in natural or hormone-prepared cycles.
This study tests if a blood test measuring tiny molecules (miRNAs) can predict when the uterus is most ready for an embryo. It aims to improve IVF success in women with unexplained repeated implantation failure.
Hear when a new In Vitro Fertilization (IVF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.